Sana Biotechnology
Facts
- HQ
- Washington state
- Sectors
- Biotechnology, Gene editing
- Founded
- 2018 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Sana Biotechnology Inc Seattle business license
- Stage
- Public
Sana Biotechnology Appoints Brian Piper as CFO; Aptevo CEO Marvin White to Step Down in April; Violett Names Scott Kushino CEO
Brian Piper was appointed CFO and executive vice president at Sana Biotechnology, while Marvin White will step down as Aptevo CEO in April, succeeded by COO Jeff Lamothe. Additionally, Scott Kushino became CEO of Seattle startup Violett, and several other leadership changes occurred across Seattle and New York tech companies.
Nobel Laureate David Baker Drives Protein Design Innovation and Startup Growth at University of Washington
David Baker, Nobel Prize winner and head of the Institute for Protein Design at the University of Washington, is focused on advancing protein design research and entrepreneurship, having helped spawn over 20 startups in Seattle's biotech hub. He plans to continue accelerating scientific innovation in the field, which develops new proteins for therapeutics, vaccines, and materials.
Seattle Tech Vet Peter Horadan Named CEO of Vouched to Lead AI-Driven Identity Verification Amid Rising Deepfake Concerns
Peter Horadan, an experienced Seattle tech executive formerly with Avalara and Lockstep, has become CEO of identity verification startup Vouched. He aims to leverage AI to address rising challenges in online identity verification amidst deepfakes, while co-founder John Baird transitions to chief strategy officer.
People
-
Steve Harr Executive, Co-founder and CEO
